Hoffman, R. M.; Umeh, O. C.; Garris, C.; Givens, N.; Currier, J. S. (2007). „Evaluation of sex differences of fosamprenavir (With and without ritonavir) in HIV-infected men and women”. HIV Clinical Trials. 8 (6): 371—380. PMID18042502. S2CID39443559. doi:10.1310/hct0806-371.
Chapman, T. M.; Plosker, G. L.; Perry, C. M. (2004). „Fosamprenavir: A review of its use in the management of antiretroviral therapy-naive patients with HIV infection”. Drugs. 64 (18): 2101—2124. PMID15341507. S2CID242117144. doi:10.2165/00003495-200464180-00014.
Wire, M. B.; Shelton, M. J.; Studenberg, S. (2006). „Fosamprenavir : Clinical pharmacokinetics and drug interactions of the amprenavir prodrug”. Clinical Pharmacokinetics. 45 (2): 137—168. PMID16485915. doi:10.2165/00003088-200645020-00002.
Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID11749573. doi:10.1021/ci000392t.
Ertl, P.; Rohde, B.; Selzer, P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID11020286. doi:10.1021/jm000942e.
Hoffman, R. M.; Umeh, O. C.; Garris, C.; Givens, N.; Currier, J. S. (2007). „Evaluation of sex differences of fosamprenavir (With and without ritonavir) in HIV-infected men and women”. HIV Clinical Trials. 8 (6): 371—380. PMID18042502. S2CID39443559. doi:10.1310/hct0806-371.
Chapman, T. M.; Plosker, G. L.; Perry, C. M. (2004). „Fosamprenavir: A review of its use in the management of antiretroviral therapy-naive patients with HIV infection”. Drugs. 64 (18): 2101—2124. PMID15341507. S2CID242117144. doi:10.2165/00003495-200464180-00014.
Wire, M. B.; Shelton, M. J.; Studenberg, S. (2006). „Fosamprenavir : Clinical pharmacokinetics and drug interactions of the amprenavir prodrug”. Clinical Pharmacokinetics. 45 (2): 137—168. PMID16485915. doi:10.2165/00003088-200645020-00002.
Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID11749573. doi:10.1021/ci000392t.
Ertl, P.; Rohde, B.; Selzer, P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID11020286. doi:10.1021/jm000942e.
semanticscholar.org
api.semanticscholar.org
Hoffman, R. M.; Umeh, O. C.; Garris, C.; Givens, N.; Currier, J. S. (2007). „Evaluation of sex differences of fosamprenavir (With and without ritonavir) in HIV-infected men and women”. HIV Clinical Trials. 8 (6): 371—380. PMID18042502. S2CID39443559. doi:10.1310/hct0806-371.
Chapman, T. M.; Plosker, G. L.; Perry, C. M. (2004). „Fosamprenavir: A review of its use in the management of antiretroviral therapy-naive patients with HIV infection”. Drugs. 64 (18): 2101—2124. PMID15341507. S2CID242117144. doi:10.2165/00003495-200464180-00014.